Critical to the establishment of effective anti-tumor immunity is the tumor-localized recruitment of antigen-specific CD8+ T cells and their subsequent activation, intratumoral migration, and resilience to immunosuppressive signals in the tumor microenvironment (TME). Here, CD8A is linked to neoplasm.